ISSN: 2641-2950
J Neurol Neurol Sci Disord
Research Article       Open Access      Peer-Reviewed

Neurological manifestations of Vitamin D deficiency among medical students

Ahmed Hassan Mitwalli*, Durdana Hammad, Rehab B Albakr, Abduallatef Alrashoudi, Abeer Aljomaiah, Sanaa Tulbah, Rawabi Albogomi, Mohammed Mitwalli and Hussam Mitwalli

King Khalid University Hospital, King Saud University, Riyadh Kingdom of Saudi Arabia
*Corresponding author: Ahmed H Mitwalli, Senior Consultant Nephrologist, King Saud University, P.O. Box 22490, Riyadh Kingdom of Saudi Arabia, E-mail: amituualli@ksu.edu.sa
Received: 22 June, 2019 | Accepted: 18 July, 2019 | Published: 19 July, 2019
Keywords: Vitamin D deficiency; Neurological manifestation of Vitamin D; Saudi Arabia; Multiple sclerosis

Cite this as

Mitwalli AH, Hammad D, Albakr RB, Alrashoudi A, Aljomaiah A, et al. (2019) Neurological manifestations of Vitamin D deficiency among medical students. J Neurol Neurol Sci Disord 5(1): 033-037. DOI: 10.17352/jnnsd.000031

Background and Objective: Vitamin D status and neurological manifestation of Vitamin D deficiency in medical students is seldom investigated. Design and settings: Cross sectional Survey conducted at King Khalid University Hospital Riyadh Saudi Arabia.

Methods: 650 medical students filled questionnaire. Serum 25- hydroxyl vitamin D 25(OH) D levels were measured for Vitamin D status, PTH and Calcium were also estimated. Vitamin D deficiency is defined as 25(OH) D < 20 ng/ml (50 nmol/liter), insufficiency ;21–29 ng/ml (52. 5– 72. 5 nmol/liter). 25(OH) D levels was assayed in serum by electro-chemi-luminescence immunoassay) ECLIA (by Cobas machine.

Results: 650 students; age 21.43+1.7yrs, mean 25 (OH) D; 43.3 ± 31.7 nmol/liter which is subnormal. 25 (OH) D Deficiency in 34(5.23%), Higher prevalence of neurological symptoms found with lowest quartile of 25 (OH) D than highest quartile. Low levels of 25 (OH) D were associated with body pains, cognitive decline, muscle weakness and visual symptoms. Inverse association was found between 25 (OH) D and Multiple sclerosis. B= - 0.072, S.E.=0.33, p=0.029, exp (B) =0.931.

Conclusion: Vitamin D deficiency is common. Neurological symptoms are associated with lower levels of 25 (OH) D. Prevalence of MS was high. Periodic assessment and supplementation of Vitamin D may reduce future disability.

Introduction

Interest in Vitamin D is surging worldwide due to its immense emerging, proven and possible benefits [1,2], in a wide range of diseases like CVD [3,4] diabetes mellitus (DM) [5,6].

Cancer [7-10], multiple sclerosis [11] and autoimmune diseases [12], part from its traditional role in the bone health and reduction of bone fractures [13,14].

Recent researches have in sighted revolutionary knowledge on diverse non-classical actions of recent researches have in sighted revolutionary knowledge on diverse non-classical actions of vitamin D which were unknown till recently. Vitamin D is emerging as neuroprotectant [15,16] and protects against Multiple Sclerosis, Epilepsy, Parkinson’s disease, Autism and Schizophrenia [17]. It has great implication in function of nervous system. Vitamin D receptors are mapped in the

Recent researches have in sighted revolutionary knowledge on diverse non-classical actions of vitamin D which were unknown till recently. Vitamin D is emerging as neuroprotectant [15,16] and protects against Multiple Sclerosis, Epilepsy, Parkinson’s disease, Autism and Schizophrenia [17]. It has great implication in function of nervous system. Vitamin D receptors are mapped in the brain [16]. Current studies have shown that vitamin D is neurotrophic and repairs nerve damage and promote its growth [17-19]. It combats neurotoxicity and protects against cognitive decline [20,21]. A recent study in 2014 have shown that vitamin D is implicated in metabolic and contractile functi

Methods

Present study was a cross sectional study conducted on randomly selected 650 medical students from all the study years, both males and females, in King Saud University, Riyadh Saudi Arabia. From January to December 2018. This research study was reviewed by the Institutional Review board (IRB) ethical committee of KKUH. The research followed the tenets of the Declaration of Helsinki. All subjects signed written consent documents after being informed of the purpose of the study including its risks and benefits and that information will be confidential.

Sample size

The presumed prevalence of Vitamin D deficiency was taken as 55% the sample size and it came to be 380 the degree of precision 0.05 and the Zα =1.96 to compensate on participate and uncompleted files. We took the sample size 650 students. Participants were asked to fill a questionnaire for the information regarding demographics, comorbidities, detailed sun exposure information how often how long how many days a week, which part of the day. Dietary habits and nutritional intake, detailed information about any atypical neurological symptoms, muscle weakness thinning of muscle ,leg pain spasm of the muscle, stiffness, numbness, visual disturbances were noted down.

25-OH Vitamin D levels was assayed in serum by electro-chemi-luminescence immunoassay (ECLIA) By Cobas machine in central lab of King Khalid University Hospital.Vitamin D deficiency is defined as 25(OH)D level of <20 ng per milliliter 50 nmol per liter which we used in our study [22-26].

Lab investigations included serum calcium, creatinine, albumin, alkaline phosphatase, PTH, 25 (OH) D levels were investigated and kept in record. Standard definitions of vitamin D defficiency, insuficiency and normal levels were used for evaluation. Lab test were performed in central lab of King Khalid University Hospital King Saud University Riyadh Saudi Arabia.

25 (OH) D and PTH were estimated by COBAS e 602, Roche Germany. The range of PTH is 1.65 to 6.9 pmol/L in our Lab. And that of 25 (OH) D is from 50-250 nmol/L. The diagnosis of multiple sclerosis was made by clinical diagnosis supported by MRI findings.

Statistical Analysis: data is represented as mean+ SD. Pearson’s correlation and binary logistic regression analysis was performed to determine the association of Vitamin D with various neurological symptoms. A p value of <0.05 was considered significant. SPSS for windows 17 (Chicago, Illinois USA) was used for statistical analysis.

Results

Total 650 students participated, 265(40.7%) males with mean age 21.43+1.7 yrs, BMI was 23.66+5.4 kg/m2. Total 9(1.5%) were diabetic, 4 (0.6%) were hypertensive. PTH was 4.02+1.6 pmol/L, serum creatinine was 70.4+16.9mmols/l, calcium was 2.3+2.2 mmols/l, Alkaline phosphatase was 95.5+25.9, albumin level was 41.9+5.1mmols/l Mean 25(OH)D level was 43.3+31.7 nmol/L, Vitamin D deficiency 25(OH)D below 20 ng/ml (50 nmol/liter) (26) was present in 34(5.23%), Vitamin D Insufficiency vitamin D insufficiency as a 25(OH)D of 21–29 ng/ml (52. 5–72. 5 nmol/liter) (26) was present in 422(64.9%)students.

Table 1 shows the atypical neurological and muscular symptoms in medical students pertaining to the highest and lowest quartile of 25(OH) D. A protective role of Vitamin D is pretty obvious. And medical students with higher levels of 25(OH) D were having less prevalence of neurological symptoms than medical students with lowest quartile of Vitamin D (Table 1).

The most common neurological and muscular manifestation was intense fatigue followed by Myalgia and Arthralgia. Other presentations included numbness of leg and face, progressive muscular weakness difficulty in getting up from squatting position, stiffness of all body muscles. Inconvenience in swallowing solid food, pain on full contraction and spasm of leg muscles. In coordination, cognitive decline difficulty in memorizing lessons, difficulty in concentration, dim vision, unexplained pain in the eye, problem in peripheral vision, dizziness and depression. 7(5.2% of the 133 students with low 25(OH) D, were diagnosed with Multiple Sclerosis.

On of cardiac and skeletal muscle [22] and its deficiency is associated with reduced muscle mass ,impaired physical performance and muscle pain [23,24]. Vitamin D deficiency is associated with incidence and progression of Multiple sclerosis [25]. Medical students are a special subset of population on which there is future responsibility of best health care provision to the community. Thus their wellbeing is of great importance. In view of prevalent Vitamin D deficiency in the region frequent Vitamin D screening and surveillance for deficiency associated neurological manifestations of Vitamin D is crucial in medical students in order to postpone and prevent neurological and muscular deficits.

Table 2 shows the bi-variate correlation of neurological symptoms with 25(OH) D level, a significant and negative correlation was found between numbness r=-0.230, p=0.012; Diagnosis of Multiple Sclerosis r=-0.123, p=0.049; PTH, r=-0.204, p=0.002; Peripheral vision defect r=-0.265, p=0.006 an inverse correlation was found between PTH levels and 25(OH)D further. A significantly positive correlation was found between 25(OH) D, and albumin r=0.138 p=0.030 (Table 2).

Table 3 shows the exact 25(OH) D level in medical students pertaining to the presence of a neurological symptom. Significantly lower levels of 25(OH) D were seen in patients with neurological symptoms. Medical students with muscular weakness had 25(OH) D level 26.7+23.4 vs 47.42+29.7 in medical students without muscular weakness.

Medical students who were previously diagnosed with multiple sclerosis had 25(OH) D levels 21.5+28.4 Vs. 46.66+30.76 in students without multiple sclerosis. Medical students who were having visual disturbances or cognitive decline had suboptimal 25(OH) D levels. Logistic regression analysis revealed that 25(OH) D deficiency contributed greater odds for having the disease. A significant negative association was found between 25(OH) D and MS. In binary logistic regression analysis Taking MS as dependent variable 25(OH) D level had a significant negative effect with B=-072; SE=0.033; Significance 0.029; Exp (B)=0.931.

Discussion

Vitamin D deficiency is often under diagnosed and undertreated. In-spite that vitamin D is an easily available safe, and affordable, inexpensive product. And vitamin D supplementation is an attractive promising intervention to alleviate several disease burdens, and to achieve better health outcome. Deficiency in vitamin D interferes with the absorption of calcium from the gastro intestinal tract, resulting in weakness and pain in the muscles and bones [27]. A recent study on Vitamin D deficiency conducted in 2009 on Saudi Arabs showed increased prevalence of Vitamin D deficiency among Saudi Arabs (both males and females) [28].

The Third National Health and Nutrition Examination Survey (2010) found that low vitamin D status is a widespread problem in the US and that serum vitamin D concentrations are related to depression in young adult in the US population [29]. Depression is one of the leading causes of disability among young adults in the US [30]. Vitamin D deficiencies can initially present as musculoskeletal pain, the populations that are most at risk are those that have decreased sun exposure.

The present study shows that 25(OH) D is a significant predictor or a risk factor for several neurological symptoms in medical students. Higher levels of 25(OH) D seem to be protective. Most but not all the neurological symptoms have a significant association with 25(OH) D status. The most common complaint was body aches, like leg pain, backache or generalized muscle pain and extreme fatigue. There is now clear evidence supporting a significant role for vitamin D in the biology and function of skeletal and cardiac muscle, including intracellular calcium handling, differentiation and contractile protein composition [31].

A better characterization of the role of Vitamin D Receptors in the context of inflammation- mediated muscle wasting and weakness may also potentially translate into significant clinical applications by using vitamin D supplementation as a potential strategy for reversing muscle wasting [32].

The prevalence of MS among the medical students was astonishing high being 1.2%of the total study population. The 25(OH) D levels in medical students with MS were lower than those without Multiple Sclerosis. There is evidence in the literature that nurses and doctors are at increased risk of developing Multiple Sclerosis. Geofry and Richard in their article have reported a high prevalence of Multiple Sclerosis in KEY West Florida USA [33]. The precise pathogenesis remains obscure.

Vitamin D deficiency seems to be an environmental risk factor for MS [34-37].

Recent studies have shown that Vitamin D deficiency is a risk factor for MS 11 Vitamin D deficiency is associated with onset progression and severity of Multiple Sclerosis.14Further vitamin D is a prognostic factor for Multiple Sclerosis. 15

The present study supports a protective effect of vitamin D intake on risk of developing MS.

Limitations

Although sample size was appropriate yet it is confined to a particular group of people the medical students and cannot be generalized to common public or population as a whole as it was not population-based. Therefore, the findings might not reflect the actual prevalence of vitamin D deficiency in the general population as a whole, but it is of significance for a group of people.

Although the 25(OH) D was estimated many times in a day but it was evaluated only once during the season. it would have been more useful if patients were evaluated at different season times of the year to determine the effects elicited by seasonal changes on vitamin D levels.

Conclusion

Vitamin D deficiency is common among medical students. Neurological symptoms are associated with lower levels of 25(OH) D. Prevalence of MS was high among medical students. Present study supports a protective effect of vitamin D intake on risk of developing MS. Periodic assessment and supplementation of Vitamin D may reduce future disability in this special group of population.

  1. Heaney RP (2008) Vitamin D in health and disease. Clin J Am Soc Nephrol 3: 1535–1541. Link: https://bit.ly/2SlSPmA
  2. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, et al. (2008) Vasan RS Vitamin D deficiency and risk of cardiovascular disease. Circulation 117: 503–511. Link: https://bit.ly/2YYOCYp
  3. Giovannucci E, Liu Y, Hollis BW, Rimm EB (2008) 25-Hydroxyvitamin D and risk of myocardial infarction in men. ArchIntern Med 168: 1174–1180. Link: https://bit.ly/2Lt8oZ0
  4. Scragg R, Sowers MF, Bell C (2004) Serum 25-hydroxyvitaminD, diabetes, and ethnicity in the Third national health and nutrition examination survey. Diabetes Care 27: 2813– 2818. Link: https://bit.ly/30MWflv
  5. Chiu KC, Chu A, Go VL, Saad MF (2004) Hypovitaminosis D isassociated with insulin resistance and b cell dysfunction. Am JClin Nutr 79: 820–825. Link: https://bit.ly/1VI0Lrn
  6. Feskanich D, Ma J, Fuchs CS, Kirkner GJ, Hankinson SE, et al. (2004) Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 13: 1501–1508. Link: https://bit.ly/32Bk0yr
  7. Jóźwicki W, Brożyna AA, Siekiera J, Slominski AT (2015) Expression of Vitamin D Receptor (VDR) Positively Correlates with Survival of Urothelial Bladder Cancer Patients. Int J Mol Sci 16: 24369-24386. Link: https://bit.ly/2JOVOA1
  8. Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P (2000) Prostate cancer risk and prediagnostic serum 25-hydroxyvitaminD levels (Finland). Cancer Causes Control 11: 847–852. Link: https://bit.ly/2XT37kc
  9. Gorham ED, Garland CF, Garland FC, Grant WM, Mohr SB, et al. (2005) Vitamin D and prevention of colorectal cancer. J SteroidBiochem Mol Biol 97: 179–194. Link: https://bit.ly/2YfHOZe
  10. Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, et al. (2008) Serum 25-hydroxyvitaminD and risk of post-menopausal breast cancer: results of alarge case-control study. Carcinogenesis 29: 93–99. Link: https://bit.ly/32BJKLa
  11. Pierrot-Deseilligny C  (2009) Clinical implications of a possiblerole of vitamin D in multiple sclerosis. J Neurol 256: 1468–1479. Link: https://bit.ly/2XP8mkN
  12. Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, et al. (2004) Vitamin D intake is inversely associated with rheumatoidarthritis: results from the Iowa Women’s Health Study.Arthritis Rheum 50: 72–77. Link: https://bit.ly/2xX8hMu
  13. Holick MF. Vitamin D deficiency (2007) N Engl J Med 357: 266–281. Link: https://bit.ly/2O1sYlf
  14. Holick MF (2004) Vitamin D: importance in the prevention ofcancers, type 1 diabetes, heart disease, and osteoporosis. Am JClin Nutr 79: 362–371. Link: https://bit.ly/2H6guop
  15. Eyles DW, Smith S, Kinobe R (2005) Distribution of the vitamin D receptors and 1 alpha – hydroxylase in human brain. Journal of chemical neuroanatomy 29: 21-30. Link: https://bit.ly/32DCfDy
  16. Lin Amy , Fan SF, Yang DM (2003) Zinc-induced apoptosis apoptosis in substantia nigra of rat brain: neuroprotection by vitamin D3.Free Radical Biology and Medicine 34: 1416– 1425. Link: https://bit.ly/32EEnuS
  17. Harms LR, Burne THJ, Darryl W (2011) Eyles(John J. McGrath, Vitamin D and The Brain. Clinical Endocrinology & Metabolism 657-669.        Link: https://bit.ly/2JE4ZV6
  18. Chabas JF, Alluin O, Rao G, Garcia S, Lavaut MN, et al. (2008) Vitamin D2 potentiates axon regeneration. J Neurotrauma 25: 1247-1256. Link: https://bit.ly/2GgDG12
  19. Liu Y, Li YW, Tang YL, Liu X, Jiang JH, et al. (2013) Vitamin D: preventive and therapeutic potential in Parkinson's disease. Curr Drug Metab 14: 989-993. Link: https://bit.ly/2Gl5aCC
  20. Brown J, Bianco JI, McGrath JJ, Eyles DW (2003) 1,25-dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci Lett 343: 139–143. Link: https://bit.ly/2LsBRT2
  21. Ibi M, Sawada H, Nakanishi M, Kume T, Katsuki H, et al. (2001) Protective effects of 1 alpha,25-(OH)(2)D(3) against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture.Neuropharmacology 40: 761–771. Link: https://bit.ly/2JF9vTf
  22. Wion D, MacGrogan D, Neveu I, Jehan F, Houlgatte R, et al. (1991) 1,25-Dihydroxyvitamin D3 is a potent inducer of nerve growth factor synthesis. J Neurosci Res 28: 110–114. Link: https://bit.ly/2O1vkAB
  23. Schlögl M, Michael F (2014) Holick2Vitamin D and neurocognitive Function in AgingClinical Interventions in Aging. 2014: 559-568. Link: https://bit.ly/2M1Abzc
  24. Polly P, Tan Timothy C (2014) The role of vitamin D in skeletal and cardiac muscle function Front Physiol.  Link: https://bit.ly/2xTcAZ9
  25. Tieland M, Brouwer-Brolsma EM, Nienaber-Rousseau C, van Loon LJ, De Groot LC (2013) Low vitamin D status is associated with reduced muscle mass and impaired physical performance in frail elderly people. Eur J Clin Nutr 67: 1050-1055. Link: https://bit.ly/2Yc5FsN
  26. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, et al. (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J ClinEndocrinolMetab 96: 1911-1930. Link: https://bit.ly/2Yc5KwB
  27. M. Y. Elsammak , A. A. Al-Wosaibi , A. Al-Howeish , J. Alsaeed (2010) vitamin D deficiency. HormMetab Res42: 364-368. Link: https://bit.ly/30KIqnB
  28. Vitamin D deficiency in Saudi Arabs (2009) The Canadian Journal of Neurological Sciences 36: 336-339.
  29. Ganji V, Milone C, Cody MM, McCarty F, Wang YT. (2010) Serum vitamin D concentrations are related to depression in young adult US population. International Archives of Medicine 3:29. Link: https://bit.ly/2Z0w4qH
  30. Abbasi M, Hashemipour S, Hajmanuchehri F, Kazemifar AM (2012) Is vitamin D deficiency associated with non specific musculoskeletal pain? Glob J Health Sci 5: 107-111. Link: https://bit.ly/2XNDIZb
  31. Polly P, Timothy C Tan (2014) The role of vitamin D in skeletal and cardiac muscle function Front Physiol. 5: 145. Link: https://bit.ly/2XS8DDq
  32. Pfeifer M, Begerow B, Minne HW (2002) Vitamin D and muscle function. Osteoporos Int 13: 187-194. Link: https://bit.ly/2GjCJoB
  33. Geoffrey D, Richard G (1990) Do nurses or doctors have an increased risk of developing multiple sclerosis? Journal of neurology, neurosurgery, and psychiatry 53: 899-902. Link: https://bit.ly/2JGmcNS
  34. Munger KL, Zhang SM, O’Reilly E, Hernán MA, Olek MJ, et al. (2004) Vitamin D intake and incidence of multiple sclerosis. Neurology January 62: 60-65. Link: http://bit.ly/2xTrjnb  
  35. Bäärnhielm M, Hedström AK, Kockum I, Sundqvist E, Gustafsson SA, et al. (2012) ,Alfredsson Sunlight is associated with decreased multiple sclerosis risk: no interaction with human leukocyte antigen-DRB1*15. Eur J Neurol 19: 955-962. Link: https://bit.ly/2JLQr4I
  36. Mesliniene S, Ramrattan L, Giddings S, Sheikh-Ali M (2013) Role of vitamin D in the onset, progression, and severity of multiple sclerosis. . Endocr Pract.19: 129-136. Link: https://bit.ly/2Yfv5pz
  37. Mowry EM (2011) Vitamin D: evidence for its role as a prognostic factor in multiple sclerosis. J Neurol Sci 311: 19-22. Link: https://bit.ly/2XWPYSp
© 2019 Mitwalli AH, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.